![Philip Toleikis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Toleikis
Directeur/Bestuurslid bij
VENTRIPOINT DIAGNOSTICS LTD.
Vermogen: 19 750 $ op 31-07-2026
Profiel
Philip M.
Toleikis is currently Director at VentriPoint Diagnostics Ltd. since 2026 and a Member of Medway Working Group.
Formerly, Dr. Toleikis was Director & Chief Technology Officer at Sernova Biotherapeutics, Inc. from 2023 to 2024 and VP-Pharmacology, Research & Development at Angiotech Pharmaceuticals, Inc. in 2006.
Education includes a doctorate from the University of British Columbia, graduate studies at the University of Michigan, and undergraduate studies at the University of Vermont.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-08-2026 | 250.000 ( 0,13% ) | 19 750 $ | 31-07-2026 |
Actieve functies van Philip Toleikis
| Bedrijven | Functie | Begin |
|---|---|---|
| VENTRIPOINT DIAGNOSTICS LTD. | Directeur/Bestuurslid | 29-07-2026 |
Medway Working Group | Corporate Officer/Principal | - |
Eerdere bekende functies van Philip Toleikis
| Bedrijven | Functie | Einde |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Algemeen Directeur | 05-09-2023 |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Hoofd Techniek/Wetenschap/O&O | 01-01-2006 |
Opleiding van Philip Toleikis
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
46
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Health Technology |
Sernova Biotherapeutics, Inc.
 Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VentriPoint Diagnostics Ltd.
 VentriPoint Diagnostics Ltd. Medical SpecialtiesHealth Technology Manufactures cardiac imaging systems | Health Technology |
Medway Working Group |
